养阴活血汤治疗糖尿病合并高血压疗效观察

目的:研究糖尿病合并高血压患者使用养阴活血汤进行治疗的临床效果。方法:选取我院2012年6月—2014年6月收治的100例糖尿病合并高血压患者,将所有患者按随机抽样法分为两组各50例,其中50例患者使用二甲双胍联合硝苯地平进行治疗作为对照组,另50例患者在对照组基础上加用养阴活血汤进行治疗作为观察组。结果:治疗后观察组患者空腹血糖浓度及收缩压、舒张压均明显低于对照组,差异有统计学意义(P0.05)。治疗期间均无不良反应发生。结论:糖尿病合并高血压患者使用养阴活血汤治疗效果显著,对血糖、血压控制效果好,值得临床应用及推广。     

Study on modified shengmai yin injection for prevention and treatment of brain impairment in endotoxin shock rats

Objective:To examine the effects of modified Shenmai Yin on invigorating vital energy, promoting blood flow, and protection against neural impairment in an endotoxin-induced shock rat model. Methods: Ninety-six SD rats were randomly divided into four groups: sham operation (saline 20 ml/kg), shock model (lipopolysaccharide, LPS, 8 mg/kg), Reformed Shengmai Yin (加味生脉饮 Pulse-activating Decoction) (LPS 8 mg/kg + reformed Shengmai Yin Injection 10 ml/kg), and dexamethasone (LPS 8 mg/kg + dexamethasone 5 mg/kg) groups. Each group was subdivided into 1 h, 2 h, 3 h, and 6 h time points for observation. The carotid artery was separated and connected with a biological functional system to monitor mean arterial pressure (MAP). Brain water levels, malonaldehyde (MDA) content, and superoxide dismutase (SOD) activity were also determined. Results: In the shock model group, MAP was progressively decreased after injection of LPS, brain water and MDA contents were increased, brain SOD activity was decreased, and capillary vessel edema in brain tissue was also observed. All these parameters were improved significantly in both treatment groups, although the effects were more marked with Shengmai Yin than with dexamethasone. Conclusion: Modified Shengmai Yin exhibits strong anti-shock and neuroprotective effects against Endotoxininduced shock.     

真武汤治疗糖尿病肾病的临床效果

目的 探析真武汤治疗糖尿病肾病的临床效果.方法 选取该院于2018年3月—2020年3月收治的100例糖尿病肾病患者,按照数字表法随机分为两组,对照组采用常规西药治疗,在此基础上观察组加用真武汤治疗,比较两组患者的临床疗效和治疗前后的相关指标变化.结果 观察组的总有效率88.0％高于对照组64.0％,差异有统计学意义(...     

三黄口服液治疗代谢综合征的疗效观察

目的:探讨三黄口服液对代谢综合征肥胖人群的临床疗效。方法:以20名健康志愿者为参照,将100名代谢综合征患者随机分为治疗组(60名)和安慰剂组(40名),分别予三黄口服液和安慰剂治疗12周,观察治疗前后患者心血管危险因素的变化。结果:与安慰剂组相比,治疗组(起效剂量为10 ml/人,黄连素浓度为0.16～0.22 mg/ml)除空腹血糖,甘油三酯在治疗前后无显著差异外,腰围、体质量指数、腰臀围比值、胰岛素抵抗指数,血清C反应蛋白水平、游离脂肪酸明显改善,差异有显著性(P<0.05);随着腰围的增大,男性的糖代谢异常、高血压病、血脂紊乱及代谢综合征的发生率均呈现增高趋势(P<0.01)。结论:三黄口服液可明显降低代谢综合征人群肥胖和胰岛素抵抗程度,并能改善炎症状态,减轻致心血管病的危险性。     

腹安汤治疗腹泻型肠易激综合征40例疗效观察及机制探讨

目的:探讨腹安汤治疗腹泻型肠易激综合征的临床疗效及对血浆血管活性肠肽(VIP)、P物质(SP)的影响。方法:将80例患者随机分为治疗组和对照组,每组40例,治疗组用腹安汤,对照组用匹维溴胺,对比两组的临床疗效和治疗前后血浆VIP、SP水平。另选20例体检健康者作正常对照。结果:治疗组总有效率92.5%,对照组总有效率77.5%,两组总有效率比较,差异有统计学意义(P<0.05);血浆VIP、SP水平在治疗组用药前后比较,有显著性差异(P<0.05),在治疗组用药后与对照组比较,有显著性差异(P<0.05)。结论:腹安汤治疗腹泻型肠易激综合征疗效明显,值得临床推广应用。其作用机制之一可能是通过调节血浆中VIP、SP的分泌而达到治疗效果。     

肠内营养合早期中药干预对胃大部切除大鼠肠道黏膜细胞更新状态的影响

目的探讨肠内营养合早期中药干预对胃大部切除大鼠肠道细胞更新状态指标(肠道黏膜细胞凋亡率)的影响及机制。方法将60只雄性SD大鼠建立胃大部切除模型,随机分成对照组(C),普通肠内营养组(EN组),肠内营养加四君子汤组(S-EN组)。从术后第1天起连续营养支持7 d,各组营养液的热量、含氮量均相同。观察术前1 d、术后1 d、3 d、7 d的肠道细胞更新状态指标(肠道黏膜细胞凋亡率)的变化。结果S-EN组术后3 d后肠道黏膜细胞凋亡率显著高于C组和EN组(P<0.05)。结论肠内营养合早期中药(四君子汤)干预可提高术后大鼠的营养状态和肠道细胞更新状态,明显改善肠黏膜屏障功能。     

高效液相色谱法测定当归补血汤分煎液与合煎液中阿魏酸含量

目的；比较当归补血汤（当归，黄芪）分煎液与合煎液中阿魏酸含量。方法：采用HypersilC18，以甲醇-0.05%乙酸（45：55）为流动相，在324nm波长处测定。结果：分煎液阿魏液平均回收率为100.86%,RSD=2.33%。合煎液阿魏酸平均回收率为101.37%,RSD=1.52%。结论：合煎液中阿魏酸含量高于分煎液。     

张念志主任医师运用三仁汤临证举隅

三仁汤为张念志常用方剂之一,本方在呼吸科应用广泛,临床上无论外感还是内伤,只需慎守湿热阻滞三焦气机之证,参以苔腻脉濡、大便不爽之症,并根据病情灵活加减便可获佳效。文章通过5则病案总结了张念志应用三仁汤的经验与体会,体现了中医学"异病同治"的核心思想。     

姜芡止泻汤治疗抗生素相关性腹泻脾肾阳虚证疗效及对肠道菌群结构的影响

目的 观察姜芡止泻汤治疗抗生素相关性腹泻(AAD)脾肾阳虚证的疗效及对肠道菌群结构的影响.方法 采用随机数字表法将120例患者分为治疗组及对照组各60例.治疗组予姜芡止泻汤,每日1剂,每日2次,口服或鼻饲;对照组予甲硝唑片+双歧杆菌三联活菌,每日3次,口服或鼻饲.2组均连续治疗7 d.观察2组临床疗效、中医症状评分、西...     

Antiosteoporotic chemical constituents from Er-Xian Decoction, a traditional Chinese herbal formula

AIM OF THE STUDY: Er Xian Decoction (EXD), a traditional Chinese medicine formula, has long been used for the treatment of osteoporosis and menopausal syndrome in China. The present study was designed to investigate the antiosteoporotic constituents of EXD, and evaluate their antiosteoporotic effects in ovariectomized rats. MATERIALS AND METHODS: Osteoblasts in neonatal calvaria cultures and osteoclasts derived from rat marrow cells were used to bioactivity-guided screen the active constituents. The proliferation of osteoblast was assayed by MTT methods. The activity of ALP and TRAP was measured by p- nitrophenyl sodium phosphate assay. The antiosteoporotic effects of icariin (1), anemarsaponin B II (8) and berberine (6) were verified by using OVX rats model. The bone mineral density (BMD) was measured by dual-energy X-ray absorptiometry using the small animal scan mode. The undecalcified longitudinal proximal tibial metaphysical (PTM) sections were cut and stained for the bone histomorphometric analysis. RESULTS: Bioactivity-guided fractionation has led to the successful isolation of antiosteoporotic constituents, i.e., icariin (1), icariside I (2), baohuoside I (3), mangiferin (4), neomangiferin (5), berberine (6), anemarsaponin B (7), anemarsaponin BII (8), anemarsaponin C (9), anemarrhenasaponin I (10), rubiadin-1-methyl ether (11) and obaculactone (12) from EXD. Further study showed that icariin (1), anemarsaponin BII (8) and berberine (6) increased the BMD in ovariectomized rats, and icariin (1) not only increased the bone formation, but also inhibited bone resorption; anemarsaponin BII (8) mainly increased bone formation and berberine (6) only inhibited the bone resorption in ovariectomized rats. CONCLUSION: Our findings demonstrate that multiple ingredients are responsible for antiosteoporotic activity in traditional Chinese medicine formula Er-Xian decoction.